PromarkerD Predictive Diagnostics For DKD To Rollout In Asia
Proteomics International raises $8m in highly successful Placement
Proteomics International Laboratories Ltd, a pioneer in predictive diagnostics, is pleased to advise that it has received firm commitments for a share placement to raise $8 million (before costs) through the issue of 9.41 million shares in the Company (the “Placement”).
The Placement was heavily oversubscribed, supported by Australian-based institutions, and sophisticated and professional investors.
Funds from the Placement (after costs) will be used for:
- Inventory build for the PromarkerD predictive test for diabetic kidney disease
- Implement US sales and marketing for PromarkerD
- Development of the Promarker™ diagnostics pipeline
- General working capital